Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd.

Healthcare

NASDAQ:DRTS · NASDAQ Capital Market

Market Cap $889.71M Beta 1.20 P/E (TTM) -15.5
$9.85 +1.76%

+$0.17 today

52W Low $2.85High $11.62

Vol 0.85M · Avg 0.67M

EPS (TTM)-$0.63
Biotechnology

Management

Put operating results in leadership context

Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.

Return Metrics

ROE, ROIC & ROA over time

Management

ROE

-55.3%

avg 628.1%

ROIC

-43.5%

avg -23.2%

ROA

-40.0%

avg -34.3%

Analysis

ROA is currently the strongest return metric at -40.0% versus its period average of -34.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Management

Key executives, compensation & ownership

Management
NameTitleCompensationTenureAgeShares OwnedOwnership %

Uzi Sofer

Chief Executive Officer & Chairman$1.26M56$1.25M1.38%

Raphi Levy

Chief Financial Officer$763,000.0041$162,680.000.18%

Robert Den

Chief Medical Officer & Member of Scientific Advisory Board$756,000.0047

Ronen Segal

Chief Technology Officer$435,000.0053

Amnon Gat

Chief Operations Officer$251,000.0051

Rebecca Becker

Vice President of legal

Yael Zeiger

Corporate Controller43

Yona Keisari

Chief Scientific Officer & Member of Scientific Advisory board79

Insider Trading

SEC Form 4 transactions — last 12 months

Management

Buys

0

$0.00

Sells

2

$352,115.25

Net Sentiment

$352,115.25

Net selling

Most Active

Levy Raphi

2 transactions

DateInsiderTypeSharesPriceValue
Jun 3, 2026

Levy Raphi

Direct

Sell15.0K$10.76$161,356.50
Jun 3, 2026

Levy Raphi

Direct

Sell17.5K$10.90$190,758.75

Analysis

Insiders reported 0 buys worth $0.00 and 2 sells worth $352,115.25 over the last 12 months. That adds up to net selling of $352,115.25. Levy Raphi was the most active insider with 2 transactions.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A2 analysts
RevenueN/AN/AN/A
N/A1 analysts
Net IncomeN/AN/AN/A
N/A1 analysts
EBITN/AN/AN/A
N/A1 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Who manages DRTS?

Alpha Tau Medical Ltd. (DRTS) lists 8 active executives. The top listed executive is Rebecca Becker, Vice President of legal.

Are DRTS insiders buying or selling?

Recent insider activity shows net selling of $352,115.25.

Explore More

Continue the stock analysis

Jump to another research area for this company.